Results 91 to 100 of about 1,471,694 (149)

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

open access: yesAnnals of Thoracic Surgery Short Reports
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD   +7 more
doaj   +1 more source

Overall (OS) and disease-free survival (DFS) after complete cytoreductive surgery in patients with DSRCT without extra-peritoneal metastases.

open access: yes, 2017
Overall (OS) and disease-free survival (DFS) after complete cytoreductive surgery in patients with DSRCT without extra-peritoneal metastases.
A. LeCesne (3778477)   +19 more
core   +1 more source

PD‐1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT In a patient with advanced ovarian cancer showing limited response to paclitaxel–carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease‐free status during olaparib–bevacizumab maintenance. This case provides a rationale for further investigation of PD‐1 blockade as neoadjuvant therapy in carefully selected ...
Wang Zhenyan, Wang Yan
wiley   +1 more source

Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?

open access: yesBMC Women's Health
Background This study aimed to determine the effect of neoadjuvant chemotherapy (NACT) on the complex surgical procedures required in addition to staging surgery for the need to achieve a residual tumor 1 cm or less in a population of stage IIIC–IV ...
Okan Aytekin   +8 more
doaj   +1 more source

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

open access: yesCurrent Oncology
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different ...
Miklos Acs   +2 more
doaj   +1 more source

Experience of applying cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian teratoma with malignant transformation and peritoneal dissemination

open access: yes, 2019
Hsin-Hsien Yu,1,2 Yutaka Yonemura,3,4 Mao-Chih Hsieh,2,5 Chang-Yun Lu,2 Szu-Yuan Wu,6,7 Yan-Shen Shan1,8 1Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Division of General Surgery, Department of ...
Wu SY   +5 more
core  

Corrigendum to ‘A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery’ Gynecol. Oncol. 139 (2015) start 401–406 [PDF]

open access: yes, 2016
Corrigendum to "A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive ...
Barber, Emma L.   +3 more
core   +1 more source

Extensive Cerebral Venous Sinus Thrombosis With Obstructive Hydrocephalus in a Young Female With Underlying Essential Thrombocythemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Persistent symptoms suggestive of idiopathic intracranial hypertension despite standard therapy should prompt urgent neuroimaging to exclude cerebral venous sinus thrombosis. When CVST is confirmed without an obvious provoking factor, evaluation for underlying myeloproliferative neoplasms, including JAK2‐positive essential thrombocythemia, is ...
Sarah Nafea   +6 more
wiley   +1 more source

Cytoreductive surgery for men with metastatic prostate cancer

open access: yesProstate International, 2016
Background: Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival.
Nikolas Katelaris   +4 more
doaj   +1 more source

Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.

open access: yes, 2011
The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies.
Fortugno A, MACRI', Antonio, Saladino E.
core  

Home - About - Disclaimer - Privacy